EIF2AK3 and metabolic dysfunction-associated steatohepatitis: In liver tissues from patients with NASH, the UPR-related PERK/ATF4/CHOP signalling pathway is activated, and blockade of this pathway partially inhibits hepatocyte apoptosis [121].